So they wisely do a Phase IIa vitiligo study in the USA, then plan on doing a Phase IIb in Europe & Asia first according to their release.
So by the sound of it, the world's largest pharmaceutical market (USA) will once again be the lagging market for another of their indications...and this after they started the vitiligo trial in the USA.
The potential giant US pharmaceutical partners and the massive vitiligo community in the USA will just love that decision...
If that's the case, YEARS away from this drug being available in the little old podunk country south of Canada and north of Mexico.
These guys should take a pharmaceutical consultant out to lunch and pick up the tab. Maybe that would finally get their share price where it should be.
$$$$$$$$$$$$$$$$$
How to spot a pumper - Tip #49: Pumpers post their pumping agenda on one forum, then save their real deep-seated concerns about the same stock on another forum under a different forum handle. Sound familiar?
So they wisely do a Phase IIa vitiligo study in the USA, then...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.37 |
Change
0.130(0.85%) |
Mkt cap ! $770.0M | |||
| Open | High | Low | Value | Volume |
| $15.36 | $15.54 | $15.18 | $1.274M | 82.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 237 | $15.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.50 | 282 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CUV (ASX) Chart |